prednisone has been researched along with piroxicam in 19 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (5.26) | 18.7374 |
1990's | 3 (15.79) | 18.2507 |
2000's | 8 (42.11) | 29.6817 |
2010's | 7 (36.84) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Carrupt, PA; Martel, S; Ottaviani, G | 1 |
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Bordas, X; Duró, JC; Herrero, C | 1 |
Litaker, DG; Longworth, DL; Stoller, JK | 1 |
Konstan, MW | 1 |
Tong, DW; Walder, BK | 1 |
Bouldin, MB; Clowers-Webb, HE; Davis, JL; Davis, MD; McEvoy, MT | 1 |
Oermann, CM | 1 |
Bevin, TH; Fuller, JR; Herbison, P; Molteno, AC; Vote, BJ | 1 |
Azizoğlu, S; Erman, B; Kavakli, IH; Kizilel, R; Kizilel, S; Marušič, M | 1 |
Ng, PS; Santosa, A; Teng, GG | 1 |
4 review(s) available for prednisone and piroxicam
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Treatment of airway inflammation in cystic fibrosis.
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Age Factors; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Chemotaxis, Leukocyte; Child; Cystic Fibrosis; Disease Progression; Fish Oils; Glucocorticoids; Humans; Ibuprofen; Inflammation; Leukocyte Elastase; Neutrophils; Pentoxifylline; Phosphodiesterase Inhibitors; Piroxicam; Pneumonia; Prednisone; Protease Inhibitors; Quality of Life | 1996 |
Naproxen-associated linear IgA bullous dermatosis: case report and review.
Topics: Aged; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Diclofenac; Humans; Immunoglobulin A; Male; Naproxen; Piroxicam; Prednisone; Skin Diseases, Vesiculobullous | 2000 |
Anti-inflammatory approaches to the treatment of cystic fibrosis lung disease: past, present and future.
Topics: alpha 1-Antitrypsin; Androstadienes; Anti-Bacterial Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Clinical Trials as Topic; Cystic Fibrosis; Fluticasone; Humans; Ibuprofen; Macrolides; Piroxicam; Prednisone; Proteinase Inhibitory Proteins, Secretory; Proteins; Serine Proteinase Inhibitors | 2001 |
15 other study(ies) available for prednisone and piroxicam
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
In silico and in vitro filters for the fast estimation of skin permeation and distribution of new chemical entities.
Topics: Humans; Membranes, Artificial; Models, Biological; Models, Molecular; Octanols; Permeability; Pharmaceutical Preparations; Skin Absorption; Water | 2007 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Piroxicam induced erythema multiforme.
Topics: Anti-Inflammatory Agents; Drug Eruptions; Erythema Multiforme; Female; Humans; Middle Aged; Piroxicam; Prednisone; Thiazines | 1984 |
Preoperative evaluation of a woman with rheumatoid arthritis.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Female; Hematoma, Subdural; Humans; Methotrexate; Middle Aged; Physical Examination; Piroxicam; Postoperative Complications; Prednisone; Preoperative Care | 1997 |
Widespread plaque psoriasis responsive to mycophenolate mofetil.
Topics: Adult; Arthritis, Psoriatic; Female; Humans; Immunosuppressive Agents; Indomethacin; Mycophenolic Acid; Piroxicam; Prednisone; Psoriasis; Treatment Outcome | 1999 |
Anti-inflammatory fibrosis suppression in threatened trabeculectomy bleb failure produces good long term control of intraocular pressure without risk of sight threatening complications.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Colchicine; Diclofenac; Drug Therapy, Combination; Female; Fibrosis; Flufenamic Acid; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Piroxicam; Prednisone; Prospective Studies; Trabecular Meshwork; Trabeculectomy; Treatment Outcome; Vision Disorders | 2002 |
Computational and experimental investigation of DNA repair protein photolyase interactions with low molecular weight drugs.
Topics: Bacterial Proteins; Deoxyribodipyrimidine Photo-Lyase; Kinetics; Loratadine; Molecular Weight; Phthalazines; Piroxicam; Prednisone; Protein Binding; Surface Plasmon Resonance; Vibrio cholerae | 2013 |
Traditional Chinese medication for rheumatoid arthritis: more than what meets the eye.
Topics: Arthritis, Rheumatoid; Diabetes Mellitus, Type 2; Drugs, Chinese Herbal; Female; Humans; Hydrochlorothiazide; Medicine, Chinese Traditional; Middle Aged; Piroxicam; Prednisone; Weight Gain | 2015 |